# Arbutus Biopharma Corp: Form DEF 14A, filed Apr 12, 2023

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: DEF 14A
- Filed: 2023-04-12
- Accepted by EDGAR: Apr 12, 2023, 16:05 ET
- Period: 2023-05-24
- Accession: 0001140361-23-017990
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000114036123017990/ny20006745x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000114036123017990/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000114036123017990/ny20006745x1_def14a.htm

Filed Apr 12, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-017990. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.